No press releases found.
(Exclusive) PRO Biotech Letter: Market Dislocation, Gilead, Corona-Portunities
Seeking Alpha (Sun, 7-Feb 2:28 AM ET)
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry.
iShares Biotechnology ETF trades on the NASDAQ stock market under the symbol IBB.
As of April 23, 2024, IBB stock price climbed to $128.02 with 1,894,368 million shares trading.
IBB has a beta of 1.00, meaning it tends to be less sensitive to market movements. IBB has a correlation of 0.53 to the broad based SPY ETF.
IBB has a market cap of $7.13 billion. This is considered a Mid Cap stock.
In the last 3 years, IBB stock traded as high as $177.37 and as low as $104.29.
IBB has underperformed the market in the last year with a price return of -3.8% while the SPY ETF gained +24.3%. IBB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.5% and -3.5%, respectively, while the SPY returned +4.9% and -2.5%, respectively.
IBB support price is $124.66 and resistance is $127.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBB stock will trade within this expected range on the day.